Published on: 19 January 2017
IMB researchers have discovered a molecular trigger for inflammation that could lead to new treatments for rheumatoid arthritis, inflammatory bowel disease and neurodegenerative diseases. Professor Jennifer Stow said targeting this trigger - a protein called SCIMP, could reduce or ‘switch off’ inflammation.